Management of a process in which a drug passes through from the manufacturer or supplier to the patient, the Drug Supply Chain is important and complex. However, this becomes even more challenging in developing countries, especially when most drugs are imported, as the chains are characterised by several levels of bureaucratic processes that make the delivery of drugs to patients, slow, labour intensive and expensive. In many instances, drug registration in the country, that may take several months to complete, is a requirement before importation is permitted. Further, import declaration fees may have to be paid for each product and, inspection done at the port of exit from the country of origin or entry into the user country. Reducing the number of products handled, which is achieved by introduction of Fixed-dose Combinations results in a more efficient system and reduces costs.